Skip to main content
OpenTrials

Clinical trial condition

Hematologic Neoplasms

Explore clinical trials studying Hematologic Neoplasms. Study availability and eligibility vary by location and protocol.

1,027 public trials 268 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Neoplasms trial results

Completed

Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis

NCT01437787

Conditions
Hematologic Diseases, Hematologic Neoplasms, Hematopoietic Neoplasm, +3 more
Locations
  • Investigational Site Number 840014 Scottsdale, Arizona, United States
  • Investigational Site Number 840001 La Jolla, California, United States
  • Investigational Site Number 840012 La Jolla, California, United States
  • Investigational Site Number 840006 Los Angeles, California, United States
View all 101 locations
View Trial Details
Completed

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

NCT01420783

Conditions
Hematologic Diseases, Hematologic Neoplasms, Hematopoietic Neoplasm, +3 more
Locations
  • Investigational Site Number 840008 Scottsdale, Arizona, United States
  • Investigational Site Number 840004 La Jolla, California, United States
  • Investigational Site Number 840005 Los Angeles, California, United States
  • Investigational Site Number 840011 Palo Alto, California, United States
View all 35 locations
View Trial Details
Completed

Phase 2 Study of SAR302503 in Patients With Myelofibrosis

NCT01420770

Conditions
Hematologic Diseases, Hematologic Neoplasms, Hematopoietic Neoplasm, +3 more
Locations
  • Investigational Site Number 840001 San Francisco, California, United States
  • Investigational Site Number 840003 Ann Arbor, Michigan, United States
  • Investigational Site Number 840006 Rochester, Minnesota, United States
  • Investigational Site Number 840007 Canton, Ohio, United States
View Trial Details
Completed

Screening Protocol for Tumor Antigen Expression Profiling and HLA Typing for Eligibility Determination

NCT02636855

Conditions
Hematologic Diseases, Hematologic Neoplasms, Hemic and Lymphatic Diseases, +7 more
Locations
  • City of Hope Duarte, California, United States
  • Stanford Cancer Institute (Stanford University) Stanford, California, United States
  • Boca Raton Regional Hospital, Lynn Cancer Institute, 701 NW 13th Street Boca Raton, Florida, United States
  • University of Miami, Sylvester Comprehensive Cancer Center Miami, Florida, United States
View all 36 locations
View Trial Details
Completed

Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant

NCT02396134

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, +46 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • University of Minnesota/Masonic Cancer Center Minneapolis, Minnesota, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
View Trial Details
Completed

A Study Of PF-04449913 In Japanese Patients With Select Hematologic Malignancies

NCT02038777

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hematologic Neoplasms, +7 more
Locations
  • Japanese Red Cross Nagoya First Hospital Nagoya, Aichi-ken, Japan
  • Kobe University Hospital Kobe, Hyōgo, Japan
  • Tohoku University Hospital Sendai, Miyagi, Japan
  • Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital Bunkyo-ku, Tokyo, Japan
View Trial Details
Completed

Safety Study of ABT-263 in Combination With Rituximab in Lymphoid Cancers

NCT00788684

Conditions
CD20-Positive Lymphoid Malignancies, Chronic Lymphoid Leukemia, Hematologic Diseases, +16 more
Locations
  • University of Arizona Cancer Center - North Campus /ID# 16721 Tucson, Arizona, United States
  • Stanford University School of Med /ID# 9782 Stanford, California, United States
  • Cleveland Clinic Main Campus /ID# 9784 Cleveland, Ohio, United States
  • Univ of Wisconsin Hosp/Clinics /ID# 21701 Madison, Wisconsin, United States
View Trial Details
Completed

Effects of Itraconazole and Rifampin on the Blood Tazemetostat Levels

NCT04537715

Conditions
Adenoma, Advanced Malignancies, All Malignancies, +32 more
Locations
  • California Cancer Associates for Research and Excellence, Inc. (cCARE) Encinitas, California, United States
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • Northwestern University-Robert H. Lurie Comprehensive Cancer Center Chicago, Illinois, United States
  • South Texas Accelerated Research Therapeutics (START) Midwest Grand Rapids, Michigan, United States
View Trial Details

Related conditions